title: [Meningitis due to Pseudomonas stutzeri: a case report].
abstract: Pseudomonas stutzeri is a saprophytic microorganism that rarely causes severe infections. In this report, a 28 days old male patient with meningomyelocele at birth was presented. The patient was admitted to the hospital with fever, and diagnosed as meningitis on the basis of physical examination and leukocytosis (blood: 16.380/mm3, cerebrospinal fluid (CSF): 130/mm3; 90% PMNL). Following diagnosis ceftriaxone therapy was started led to improvement in clinical and laboratory findings. However on the 20th day, the clinical signs and symptoms became worse, and the patient was diagnosed to develop a second meningitis attack by laboratory examination of CSF. P. stutzeri was isolated from the CSF culture, and the isolate was found to be resistant to ceftriaxone. Upon this result the therapy has changed to meropenem. On the 5th day of the therapy, the patient has slightly improved and he was discharged due to the wishes of his parents, however he died two days after discharge. This first case of P. stutzeri meningitis in neonates was presented to withdraw attention to this clinical entity.
authors.affiliation: Ondokuz Mayis Universitesi Tip Fakültesi, infeksiyon Hastaliklari ve Klinik Mikrobiyoloji Anabilim Dali, Samsun.
authors.forename: Nuriye
authors.initials: N
authors.lastname: Taşdelen Fişgin
authors.forename: Ibrahim Cağatay
authors.initials: IC
authors.lastname: Acuner
authors.forename: Ahmet Yilmaz
authors.initials: AY
authors.lastname: Coban
authors.forename: Tunç
authors.initials: T
authors.lastname: Fişgin
authors.forename: Asuman
authors.initials: A
authors.lastname: Birinci
authors.forename: Belma
authors.initials: B
authors.lastname: Durupinar
mesh_terms: D000900:Anti-Bacterial Agents / Q000494:pharmacology / Q000627:therapeutic use; D002443:Ceftriaxone / Q000494:pharmacology / Q000627:therapeutic use; D002555:Cerebrospinal Fluid / Q000382:microbiology*; D024881:Drug Resistance, Bacterial; D017809:Fatal Outcome; D006801:Humans; D007231:Infant, Newborn; D008297:Male; D016920:Meningitis, Bacterial / Q000175:diagnosis* / Q000188:drug therapy / Q000382:microbiology; D008591:Meningomyelocele / Q000150:complications*; D000077731:Meropenem; D011552:Pseudomonas Infections / Q000175:diagnosis* / Q000188:drug therapy / Q000382:microbiology; D044223:Pseudomonas stutzeri / Q000187:drug effects / Q000302:isolation & purification*; D012008:Recurrence; D013845:Thienamycins / Q000627:therapeutic use; D017211:Treatment Failure
chemical_list: D000900:Anti-Bacterial Agents; D013845:Thienamycins; D002443:Ceftriaxone; D000077731:Meropenem